Market Access
What the revised 340B rebate pilot programme means for pharm...
While the scope of the revised pilot is limited, it may be a harbinger for a broader policy shift.
News
Grail cancer test gets lukewarm backing from FDA adcomm
FDA expert advisors voted in favour of Grail's Galleri blood test for detecting multiple cancers, but some expressed misgivings about its efficacy.
News
Pharma leaders urge Europe to halt 'slow agony' of decline
Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."
News
UK first country to launch CSL's trivalent flu shot Aujemflu
CSL Seqirus' recently approved trivalent, cell-based influenza vaccine Aujemflu will be part of the UK's 2027/28 immunisation campaign.
News
Advocacy group pokes holes in Trump's MFN pricing claims
Public Citizen says claims for the drug price savings that are being delivered by Trump's Most-Favoured Nation deals with pharma are "a mirage."
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
